loncastuximab tesirine-lpyl
Brand: ZYNLONTA
approved
Quick answer
loncastuximab tesirine-lpyl (ZYNLONTA), is a pharmaceutical active ingredient, associated with ADC Therapeutics SA, with approved status in the US.
Key facts
- INN
- loncastuximab tesirine-lpyl
- Brand
- ZYNLONTA
- Route
- INJECTION
- Formulation
- INJECTABLE
- Originator
- ADC Therapeutics SA
Frequently asked questions
What is loncastuximab tesirine-lpyl?
loncastuximab tesirine-lpyl (ZYNLONTA), is a pharmaceutical active ingredient, associated with ADC Therapeutics SA, with approved status in the US.
What is the brand name for loncastuximab tesirine-lpyl?
ZYNLONTA is a marketed brand name for loncastuximab tesirine-lpyl. Check FDA Drugs@FDA for the current US label holder.